BASF Valuation

Is BFFA.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BFFA.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: BFFA.F ($44.64) is trading below our estimate of fair value ($132.53)

Significantly Below Fair Value: BFFA.F is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for BFFA.F?

Key metric: As BFFA.F is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for BFFA.F. This is calculated by dividing BFFA.F's market cap by their current earnings.
What is BFFA.F's PE Ratio?
PE Ratio76.9x
Earnings€497.00m
Market Cap€38.21b

Price to Earnings Ratio vs Peers

How does BFFA.F's PE Ratio compare to its peers?

The above table shows the PE ratio for BFFA.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average48.2x
CC Chemours
37.1xn/aUS$2.8b
CTVA Corteva
59.7x26.4%US$40.0b
DD DuPont de Nemours
66.9x25.2%US$34.0b
DOW Dow
29.1x28.5%US$30.7b
76.9x34.2%US$38.2b

Price-To-Earnings vs Peers: BFFA.F is expensive based on its Price-To-Earnings Ratio (76.9x) compared to the peer average (48.2x).


Price to Earnings Ratio vs Industry

How does BFFA.F's PE Ratio compare vs other companies in the US Chemicals Industry?

7 CompaniesPrice / EarningsEstimated GrowthMarket Cap
FFHL Fuwei Films (Holdings)
2.8xn/aUS$27.11m
BSLK Bolt Projects Holdings
0.06xn/aUS$9.40m
BON Bon Natural Life
2.2xn/aUS$5.36m
GSPI Green Star Products
1.5xn/aUS$1.49m
BFFA.F 76.9xIndustry Avg. 22.6xNo. of Companies7PE01224364860+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: BFFA.F is expensive based on its Price-To-Earnings Ratio (76.9x) compared to the US Chemicals industry average (22.6x).


Price to Earnings Ratio vs Fair Ratio

What is BFFA.F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BFFA.F PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio76.9x
Fair PE Ratio37.4x

Price-To-Earnings vs Fair Ratio: BFFA.F is expensive based on its Price-To-Earnings Ratio (76.9x) compared to the estimated Fair Price-To-Earnings Ratio (37.4x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst BFFA.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$44.64
US$56.20
+25.9%
9.8%US$68.43US$49.48n/a21
Nov ’25US$47.74
US$56.92
+19.2%
11.3%US$70.44US$46.60n/a21
Oct ’25US$52.00
US$58.34
+12.2%
13.0%US$72.58US$46.90n/a20
Sep ’25US$50.01
US$58.40
+16.8%
13.7%US$76.82US$46.09n/a19
Aug ’25US$46.88
US$58.30
+24.4%
13.1%US$75.80US$45.48n/a19
Jul ’25US$47.52
US$58.77
+23.7%
12.9%US$77.31US$46.17n/a19
Jun ’25US$52.31
US$60.65
+16.0%
12.1%US$78.35US$46.79n/a19
May ’25US$50.54
US$59.44
+17.6%
12.1%US$76.86US$45.90n/a19
Apr ’25US$56.94
US$56.61
-0.6%
13.3%US$67.67US$44.04n/a20
Mar ’25US$50.94
US$54.39
+6.8%
13.3%US$67.25US$42.30n/a20
Feb ’25US$47.48
US$53.08
+11.8%
13.8%US$67.30US$42.34n/a19
Jan ’25US$54.12
US$55.36
+2.3%
12.1%US$68.28US$42.95n/a19
Dec ’24US$46.05
US$53.80
+16.8%
13.7%US$68.11US$42.84n/a21
Nov ’24US$45.00
US$51.91
+15.4%
13.1%US$65.52US$39.10US$47.7421
Oct ’24US$44.28
US$53.48
+20.8%
13.4%US$67.23US$38.87US$52.0021
Sep ’24US$51.41
US$55.75
+8.4%
12.3%US$69.53US$43.45US$50.0121
Aug ’24US$54.16
US$56.52
+4.4%
12.2%US$70.29US$43.93US$46.8821
Jul ’24US$47.97
US$58.27
+21.5%
15.1%US$81.51US$46.73US$47.5222
Jun ’24US$48.17
US$58.78
+22.0%
17.0%US$81.57US$33.74US$52.3122
May ’24US$51.81
US$59.09
+14.1%
16.5%US$78.99US$34.04US$50.5422
Apr ’24US$51.85
US$58.29
+12.4%
16.0%US$73.71US$33.63US$56.9422
Mar ’24US$51.38
US$57.43
+11.8%
15.6%US$72.13US$32.91US$50.9422
Feb ’24US$57.25
US$58.22
+1.7%
15.7%US$73.99US$33.76US$47.4822
Jan ’24US$49.85
US$57.53
+15.4%
17.2%US$76.92US$33.15US$54.1223
Dec ’23US$51.90
US$56.29
+8.5%
18.0%US$78.09US$32.30US$46.0523
Nov ’23US$43.30
US$52.55
+21.4%
17.3%US$74.08US$30.65US$45.0023

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies